• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植后肥胖会影响长期生存。

Post-transplant obesity impacts long-term survival after liver transplantation.

机构信息

Department of Surgery, Division of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

出版信息

Metabolism. 2020 May;106:154204. doi: 10.1016/j.metabol.2020.154204. Epub 2020 Mar 13.

DOI:10.1016/j.metabol.2020.154204
PMID:32173406
Abstract

BACKGROUND

Short-term survival after orthotopic liver transplantation (OLT) has improved over the past decades, but long-term survival remains impaired. The effects of obesity on long-term survival after OLT are controversial. Because pre-transplant body mass index (BMI) can be confounded by ascites, we hypothesized that post-transplant BMI at 1 year could predict long-term survival.

METHODS

A post-hoc analysis was performed of an observational cohort study consisting of adult recipients of a first OLT between 1993 and 2010. Baseline BMI was measured at 1-year post-transplantation to represent a stable condition. Recipients were stratified into normal weight (BMI < 25 kg/m), overweight (25 ≤ BMI ≤ 30 kg/m), and obese (BMI > 30 kg/m). Kaplan-Meier survival analyses were performed with log-rank testing, followed by multivariable Cox proportional hazards regression analysis.

RESULTS

Out of 370 included recipients, 184 had normal weight, 136 were overweight, and 50 were obese at 1-year post-transplantation. After median follow-up for 12.3 years, 107 recipients had died, of whom 46 (25%) had normal weight, 39 (29%) were overweight, and 22 (44%) were obese (log-rank P = 0.020). Obese recipients had a significantly increased mortality risk compared to normal weight recipients (HR 2.00, 95% CI 1.08-3.68, P = 0.027). BMI was inversely associated with 15 years patient survival (HR 1.08, 95% CI 1.03-1.14, P = 0.001 per kg/m), independent of age, gender, muscle mass, transplant characteristics, cardiovascular risk factors, kidney- and liver function.

CONCLUSION

Obesity at 1-year post-transplantation conveys a 2-fold increased mortality risk, which may offer potential for interventional strategies (i.e. dietary advice, lifestyle modification, or bariatric surgery) to improve long-term survival after OLT.

摘要

背景

在过去的几十年中,原位肝移植(OLT)后的短期存活率有所提高,但长期存活率仍然较差。肥胖对 OLT 后长期存活率的影响存在争议。由于移植前的体重指数(BMI)可能会受到腹水的影响,我们假设移植后 1 年的 BMI 可以预测长期存活率。

方法

对 1993 年至 2010 年间接受首次 OLT 的成人患者的观察队列研究进行了事后分析。在移植后 1 年测量基线 BMI,以代表稳定状态。将患者分为正常体重(BMI<25kg/m)、超重(25≤BMI≤30kg/m)和肥胖(BMI>30kg/m)。采用对数秩检验进行 Kaplan-Meier 生存分析,然后进行多变量 Cox 比例风险回归分析。

结果

在 370 名纳入的受者中,184 名在移植后 1 年时体重正常,136 名超重,50 名肥胖。中位随访 12.3 年后,107 名受者死亡,其中 46 名(25%)体重正常,39 名(29%)超重,22 名(44%)肥胖(对数秩 P=0.020)。与体重正常的受者相比,肥胖的受者死亡风险显著增加(HR 2.00,95%CI 1.08-3.68,P=0.027)。BMI 与 15 年患者生存率呈负相关(HR 1.08,95%CI 1.03-1.14,每公斤/m 增加 P=0.001),独立于年龄、性别、肌肉量、移植特征、心血管危险因素、肾功能和肝功能。

结论

移植后 1 年肥胖使死亡率增加 2 倍,这可能为干预策略(即饮食建议、生活方式改变或减肥手术)提供了改善 OLT 后长期存活率的机会。

相似文献

1
Post-transplant obesity impacts long-term survival after liver transplantation.肝移植后肥胖会影响长期生存。
Metabolism. 2020 May;106:154204. doi: 10.1016/j.metabol.2020.154204. Epub 2020 Mar 13.
2
Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis.一项单机构分析显示,肝移植受者的病态肥胖对长期移植物和患者生存产生不利影响。
HPB (Oxford). 2015 Mar;17(3):251-7. doi: 10.1111/hpb.12340. Epub 2014 Oct 17.
3
Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.低体重指数而非高体重指数会增加肝移植后死亡和移植物丢失的风险:风险受终末期肝病模型调节。
Liver Transpl. 2015 Oct;21(10):1286-94. doi: 10.1002/lt.24188.
4
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom.超重和肥胖的肝移植受者发病率增加:英国 1325 例患者的单中心经验。
Liver Transpl. 2013 May;19(5):551-62. doi: 10.1002/lt.23618. Epub 2013 Mar 17.
5
Comorbidities have a limited impact on post-transplant survival in carefully selected cirrhotic patients: a population-based cohort study.合并症对精心挑选的肝硬化患者移植后生存率的影响有限:一项基于人群的队列研究。
Ann Hepatol. 2015 Jul-Aug;14(4):505-14.
6
Association of overweight with postoperative acute kidney injury among patients receiving orthotopic liver transplantation: an observational cohort study.超重与接受原位肝移植患者术后急性肾损伤的相关性:一项观察性队列研究。
BMC Nephrol. 2020 Jun 11;21(1):223. doi: 10.1186/s12882-020-01871-0.
7
The Effect of Recipient Body Mass Index and Its Extremes on Survival and Graft Vascular and Biliary Complications After Liver Transplantation: A Single Center Retrospective Study.受体体重指数及其极端值对肝移植术后生存、移植血管及胆道并发症的影响:一项单中心回顾性研究
Ann Transplant. 2017 Oct 13;22:611-621. doi: 10.12659/aot.903475.
8
Renaissance of Modified Charlson Comorbidity Index in Prediction of Short- and Long-Term Survival After Liver Transplantation?改良 Charlson 共病指数在肝移植后短期和长期生存预测中的复兴?
Med Sci Monit. 2019 Jun 18;25:4521-4526. doi: 10.12659/MSM.914669.
9
Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.大脂变同种异体移植物和肥胖受者对肝移植存活的负面影响几乎相等。
Transplantation. 2020 Jun;104(6):1193-1200. doi: 10.1097/TP.0000000000002990.
10
Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.肥胖及其对美国接受原位肝移植患者生存率的影响。
Hepatology. 2002 Jan;35(1):105-9. doi: 10.1053/jhep.2002.30318.

引用本文的文献

1
Are we standing on the shifting sands of post-transplant metabolic-associated steatotic liver disease?我们是否正站在移植后代谢相关脂肪性肝病这一变幻莫测的领域?
World J Hepatol. 2025 Jul 27;17(7):107837. doi: 10.4254/wjh.v17.i7.107837.
2
Factors Affecting Health-Related Quality of Life in Patients After a Liver Transplant: A Cross-Sectional, Single-Centre, Large-Cohort Study.肝移植术后患者健康相关生活质量的影响因素:一项横断面、单中心、大样本队列研究
J Clin Med. 2025 Jun 25;14(13):4507. doi: 10.3390/jcm14134507.
3
Home-based exercise and PHysical activity maintenance interventiOn after livEr traNsplantation: Impact of eXercise intensity (PHOENIX-Liver).
肝移植后居家锻炼与身体活动维持干预:运动强度的影响(PHOENIX-肝脏研究)
BMJ Open Sport Exerc Med. 2025 Mar 15;11(1):e002436. doi: 10.1136/bmjsem-2024-002436. eCollection 2025.
4
Key challenges of post-liver transplant weight management.肝移植后体重管理的关键挑战。
World J Transplant. 2024 Dec 18;14(4):95033. doi: 10.5500/wjt.v14.i4.95033.
5
Evolution of liver transplantation in the metabolic dysfunction-associated steatotic liver disease era: Tracking impact through time.代谢功能障碍相关脂肪性肝病时代肝移植的演变:随时间追踪影响
World J Transplant. 2024 Dec 18;14(4):98718. doi: 10.5500/wjt.v14.i4.98718.
6
Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis.肝移植受者中现代降糖药物的应用:体重、血糖控制及可能的移植肝脂肪变性均得到改善。
Front Transplant. 2023 Nov 30;2:1223169. doi: 10.3389/frtra.2023.1223169. eCollection 2023.
7
Obesity, organ failure, and transplantation: a review of the role of metabolic and bariatric surgery in transplant candidates and recipients.肥胖、器官衰竭与移植:代谢与减重手术在移植候选者和受者中的作用综述。
Surg Endosc. 2024 Aug;38(8):4138-4151. doi: 10.1007/s00464-024-10930-8. Epub 2024 Jul 1.
8
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).EASL-EASD-EASO 临床实践指南:代谢功能障碍相关脂肪性肝病(MASLD)的管理。
Obes Facts. 2024;17(4):374-444. doi: 10.1159/000539371. Epub 2024 Jun 7.
9
Biguanides and glucagon like peptide 1 receptor agonists in the amelioration of post liver transplant weight gain; a scoping review of the mechanism of action, safety and efficacy.双胍类药物和胰高血糖素样肽1受体激动剂改善肝移植后体重增加的作用机制、安全性及疗效的范围综述
Gastroenterol Hepatol Bed Bench. 2024;17(1):17-27. doi: 10.22037/ghfbb.v17i1.2899.
10
Waitlisting and liver transplantation for MetALD in the United States: An analysis of the UNOS national registry.美国代谢性酒精性肝病的等待名单与肝移植:对器官共享联合网络国家登记处的分析
Hepatology. 2025 Feb 1;81(2):532-545. doi: 10.1097/HEP.0000000000000914. Epub 2024 Apr 29.